 ProductsFriends links |
|
Company Profile
Biotest's mission is to "provide customers with accurate, convenient and affordable medical test products." Our elite employees possess the talent and prowess to drive the accelerated yet sustainable development of our enterprises. Over the years, Biotest has been steadfast in adhering to the principle of fostering healthy lives and is committed to funding the constant innovation required to continue our goal of overall wellness for mankind.
Factory View
Hangzhou Biotest Biotech Co., Ltd. – a National High-tech Enterprise, is a professional manufacturer specializing in medical in vitro diagnostic assays and reagents,instrument research and development, and world-class sales and service. Biotest was established in 2008 with headquarters located in the natural scenic Eco-Industrial Park Yuhang District of Hangzhou city. Our flagship facility consists of an area of 85,000 square meters with registered capital of 106 million RMB.
Hangzhou Biotest Biotech Co., Ltd. supplies major IVD categories: fertility health, drug testing/toxicology, infectious disease identification, tumor marker detection and cardiac marker monitoring. Biotest harnesses the world-leading technologies of bioengineering by using gene recombinant antigens, synthetic antigens, mono-specific antibodies and polyclonal antibodies combined with latex and colloidal metal particles on immuno-chromatographic assay scaffold to accomplish our test development goals.
The company's main products are developed based on the preparation and labeling technology of colloidal gold/latex/fluorescent particles, immunochromatography technology, monoclonal antibody technology, etc. Compared with traditional diagnostic methods, they have strong specificity, high sensitivity, it is simple, fast, and cost-effective. Generally does not require special equipment, and suitable for large-scale screening. At the same time, Biotest continues to invest in molecular diagnostic technology platform and animal disease detection service platform related technology reserves, as a strategic technology platform, laying the foundation for continuous business technology innovation in the future.
Since its establishment, the company has focused on research in the field of biotechnology and R&D of bio-high-tech products. As of December 2023, the company has 230 patented technologies, including 171 domestic patents (9 invention patents) and 59 overseas patents (7 Invention patents).
Obtained 45 NMPA certificates, EU CE certificates covering 603 products, and 3 US FDA 510(k) certificates covering 21 test products. Products are sold to more than 100 countries and regions around the world.
Why choose Biotest
Here Are two Reasons Why You Choose Us
To provide you with satisfactory service
In 2015, Hangzhou Biotest Biotech Co., Ltd completed the acquisition of Advin Biotechnology Co., Ltd. of the United States. With the technology and talent advantages of the Silicon Valley of the United States, and adhering to the strategy of global research and development, Biotest not only established to provide innovative, timely, high-quality products for the global market, but also offering solution program and development center.
Hangzhou Biotest Biotech Co., Ltd
In 2015, Biotest embarked on the new journey of strategic global deployment by acquiring the American company Advin Biotech, Incorporated. This event marked our resolve towards penetrating the highly coveted American market. Advin Biotech is FDA registered and specializes in toxicology products including single drug combination and multiple drug combination detection kits. The company provides the most comprehensive drug detection tests for the American and global drug-testing markets including employee screening, medical diagnostics, judicial compliance and military testing.
|
| Company Name: |
Hangzhou Biotest Biotech Co., Ltd. |
Type of company: |
Enterprise Units () |
| Place of Origin: |
Zhejiang |
Company Size: |
|
| Registered Capital: |
Not filled |
Year of Registration: |
2002 |
| Data certification: |
      Enterprise data throughAuthenticate
|
| Industry: |
|
|
E-mail: 